• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Rchr
J-GLOBAL ID:202501003879156574   Update date: Jan. 20, 2025

Shitaoka Kiyomi

シタオカ キヨミ | Shitaoka Kiyomi
Affiliation and department:
Papers (12):
  • Rin Yoshizato, Mariko Miura, Kiyomi Shitaoka, Yuri Matsuoka, Akifumi Higashiura, Akima Yamamoto, Yun Guo, Hitoshi Azuma, Yohei Kawano, Shouichi Ohga, et al. Comprehensive method for producing high-affinity mouse monoclonal antibodies of various isotypes against (4-hydroxy-3-nitrophenyl)acetyl (NP) hapten. Heliyon. 2024. 10. 23. e40837
  • My Thi Viet Ha, Hiroshi Hamana, Kiyomi Shitaoka, Abdul Hayee, Eiji Kobayashi, Toshiaki Yoshikawa, Tetsuya Nakatsura, Reiko Saikawa, Eri Sato, Mitsujiro Osawa, et al. Selection of highly responsive T cell receptors by an analysis combining the expression of multiple markers. Cancer science. 2023. 114. 6. 2254-2264
  • Kiyomi Shitaoka, Akifumi Higashiura, Yohei Kawano, Akima Yamamoto, Yoko Mizoguchi, Takao Hashiguchi, Norihisa Nishimichi, Shiyu Huang, Ayano Ito, Shun Ohki, et al. Structural basis of spike RBM-specific human antibodies counteracting broad SARS-CoV-2 variants. Communications biology. 2023. 6. 1. 395-395
  • Hitoshi Azuma, Yohei Kawano, Kiyomi Shitaoka, Takahiro Kawahara, Ayano Ito, Akifumi Higashiura, Yasuo Kitajima, Shun Ohki, Tomoharu Yasuda. Vaccination with the Omicron spike RBD boosts broadly neutralizing antibody levels and confers sustained protection even after acquiring immunity to the original antigen. International immunology. 2023. 35. 4. 197-207
  • Eiji Kobayashi, Aishun Jin, Hiroshi Hamana, Kiyomi Shitaoka, Kazuto Tajiri, Seisuke Kusano, Shigeyuki Yokoyama, Tatsuhiko Ozawa, Tsutomu Obata, Atsushi Muraguchi, et al. Rapid cloning of antigen-specific T-cell receptors by leveraging the cis activation of T cells. Nature biomedical engineering. 2022. 6. 7. 806-818
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page